Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-18.71	-74.83	-63.04
Graham Fair Price	-16.39	0.05	0.05
PEG	14.22	0.63	-0.55
Price/Book	-21.10	1.25	1.58
Price/Cash Flow	56.18	-18.81	-42.93
Prices/Earnings	-11.05	-17.43	-15.69
Price/Sales	-25.25	121.07	161.96
Price/FCF	56.18	-18.81	-42.93
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-10.74	-1.84	-1.66
Operating Margin	35.72	-1.53	-2.38
ROA	47.23	-0.01	-0.02
ROE	-0.03	-0.02	28.95
ROIC	-0.02	-0.02	30.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.03	-0.03	-13.35
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.33	0.33	-0.14
EPS QOQ	-0.29	0.28	-2.78
FCF QOQ	-0.58	-0.79	-35.06
Revenue QOQ	0.19	0.05	-75.17
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	208.14	1500.04	620.70
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.43	0.06	-86.12
Debt/Capitalization	0.04	0.03	-2.29
Quick Ratio	2.48	0.31	-87.35
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.07	0.07	-0.82
Cash	< 0.005	< 0.005	-7.45
Capex	< 0.005	< 0.005	50.91
Free Cash Flow	< 0.005	< 0.005	-78.59
Revenue	< 0.005	< 0.005	4.69
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	12.32	2.60	-78.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.92	4.17	6.28
Naive Interpretation	Member

06 - Financial Health · Bad

Rating